Vimarsana
Biggest News Aggregation in the World

Page 9 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $29.00 - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $29.00

BridgeBio Pharma (NASDAQ:BBIO – Get Rating) had its price target boosted by Mizuho from $23.00 to $29.00 in a research note issued to investors on Monday, The Fly reports. A number of other equities research analysts have also recently commented on BBIO. The Goldman Sachs Group raised their price target on BridgeBio Pharma from $20.00 […]

Mizuho Boosts BridgeBio Pharma (NASDAQ:BBIO) Price Target to $29.00 - Vimarsana News

Mizuho Boosts BridgeBio Pharma (NASDAQ:BBIO) Price Target to $29.00

BridgeBio Pharma (NASDAQ:BBIO – Get Rating) had its target price boosted by Mizuho from $23.00 to $29.00 in a report released on Monday, The Fly reports. A number of other analysts have also issued reports on the company. The Goldman Sachs Group raised their price target on BridgeBio Pharma from $20.00 to $28.00 and gave […]

BridgeBio Pharma (NASDAQ:BBIO) Releases Earnings Results - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Releases Earnings Results

BridgeBio Pharma (NASDAQ:BBIO – Get Rating) posted its quarterly earnings results on Thursday. The company reported ($0.92) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.09), Briefing.com reports. The business had revenue of $1.83 million during the quarter, compared to analysts’ expectations of $3.23 million. During the same quarter […]

Source: wkrb13.com
BridgeBio Pharma (NASDAQ:BBIO) Announces Quarterly Earnings Results - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Announces Quarterly Earnings Results

BridgeBio Pharma (NASDAQ:BBIO – Get Rating) issued its quarterly earnings results on Thursday. The company reported ($0.92) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.09), Briefing.com reports. The business had revenue of $1.83 million for the quarter, compared to the consensus estimate of $3.23 million. The company’s revenue was […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Fernwood Investment Management LLC - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Fernwood Investment Management LLC

Fernwood Investment Management LLC trimmed its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) by 0.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 203,000 shares of the company’s stock after selling 1,550 shares during the period. […]